Clinicians should be cognizant of this drug reaction associated with the use of modafinil, especially because there is an increasing trend of off-label use for depression, attention-deficit/hyperactivity disorder, and Parkinson disease.
← all excerpts
Modafinil-induced drug reaction with eosinophilia and systemic symptoms syndrome.
1
—
—